Literature DB >> 8785025

An investigation of the activities of 3-hydroxykynureninase and kynurenine aminotransferase in the brain in Huntington's disease.

S J Pearson1, A Meldrum, G P Reynolds.   

Abstract

Previous reports have indicated abnormalities in the concentrations of metabolites of the tryptophan/kynurenine pathway in the brain in Huntington's disease. These have included an increase in 3-hydroxykynurenine and both increases and decreases in kynurenic acid. The activities of two enzymes involved in the metabolism of these compounds, 3-hydroxykynureninase and kynurenine aminotransferase, have been determined in post mortem brain tissue taken from Huntington's disease patients and control subjects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8785025     DOI: 10.1007/bf01276566

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  23 in total

1.  Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease.

Authors:  L S Dure; A B Young; J B Penney
Journal:  Ann Neurol       Date:  1991-12       Impact factor: 10.422

2.  Organ distribution of rat kynureninase and changes of its activity during development.

Authors:  J Kawai; E Okuno; R Kido
Journal:  Enzyme       Date:  1988

3.  The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine.

Authors:  C L Eastman; T R Guilarte
Journal:  Neurochem Res       Date:  1990-11       Impact factor: 3.996

4.  Two kynurenine aminotransferases in human brain.

Authors:  E Okuno; M Nakamura; R Schwarcz
Journal:  Brain Res       Date:  1991-03-01       Impact factor: 3.252

5.  Deficit of [3H]L-689,560 binding to the glycine site of the glutamate/NMDA receptor in the brain in Huntington's disease.

Authors:  G P Reynolds; S J Pearson; P H Hutson
Journal:  J Neurol Sci       Date:  1994-08       Impact factor: 3.181

6.  Purification and properties of kynureninase from rat liver.

Authors:  F Takeuchi; H Otsuka; Y Shibata
Journal:  J Biochem       Date:  1980-10       Impact factor: 3.387

7.  Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain.

Authors:  R Schwarcz; W O Whetsell; R M Mangano
Journal:  Science       Date:  1983-01-21       Impact factor: 47.728

Review 8.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

Authors:  M F Beal
Journal:  Ann Neurol       Date:  1992-02       Impact factor: 10.422

9.  Determination of 3-hydroxykynurenine in human brain and plasma by high-performance liquid chromatography with electrochemical detection. Increased concentrations in hepatic encephalopathy.

Authors:  S J Pearson; G P Reynolds
Journal:  J Chromatogr       Date:  1991-04-19

10.  Increased concentrations of the neurotoxin 3-hydroxykynurenine in the frontal cortex of HIV-1-positive patients.

Authors:  A M Sardar; J E Bell; G P Reynolds
Journal:  J Neurochem       Date:  1995-02       Impact factor: 5.372

View more
  6 in total

1.  Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington's disease.

Authors:  Korrapati V Sathyasaikumar; Erin K Stachowski; Laura Amori; Paolo Guidetti; Paul J Muchowski; Robert Schwarcz
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

Review 2.  Involvement of kynurenines in Huntington's disease and stroke-induced brain damage.

Authors:  Trevor W Stone; Caroline M Forrest; Nicholas Stoy; L Gail Darlington
Journal:  J Neural Transm (Vienna)       Date:  2011-06-22       Impact factor: 3.575

Review 3.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 4.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

5.  Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.

Authors:  Mobina Fathi; Kimia Vakili; Shirin Yaghoobpoor; Arian Tavasol; Kimia Jazi; Ramtin Hajibeygi; Sina Shool; Fatemeh Sodeifian; Andis Klegeris; Alyssa McElhinney; Mostafa Rezaei Tavirani; Fatemeh Sayehmiri
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

6.  Indoleamine 2,3-dioxygenase overexpression causes kynurenine-modification of proteins, fiber cell apoptosis and cataract formation in the mouse lens.

Authors:  Maneesh Mailankot; Magdalena M Staniszewska; Heather Butler; Moonkyung H Caprara; Scott Howell; Benlian Wang; Catherine Doller; Lixing W Reneker; Ram H Nagaraj
Journal:  Lab Invest       Date:  2009-03-23       Impact factor: 5.662

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.